We have located links that may give you full text access.
Development and validation of risk matrices concerning ulcerative colitis outcomes - Bayesian network analysis.
Journal of Crohn's & Colitis 2018 October 18
Introduction: Ulcerative colitis (UC) is a chronic inflammatory disease often accompanied by severe and distressing symptoms that, in some patients, might require a surgical intervention (colectomy). This study aimed at determining the risk of experiencing progressive disease or requiring colectomy.
Material and Methods: This was a multicenter study: patients' data (n=1481) was retrieved from the Portuguese database of inflammatory bowel disease patients. Bayesian networks and logistic regression were used to build risk matrices concerning the outcomes of interest.
Results: The derivation cohort included a total of 1210 patients, of which 6% required a colectomy and 37% had progressive disease (over a median follow-up period of 12 years). The risk matrices show that previously hospitalized patients with extensive disease who are not on immunomodulators and who are refractory to corticosteroid treatment are the ones at the highest risk of undergoing a colectomy (88%), whereas male patients with extensive disease and less than 40 years old at diagnosis are the ones at the highest risk of experiencing progressive disease (72%). These results were internally- and externally-validated, and the AUC (area under the curve) of the ROC (receiver operating characteristic) analysis for the derivation cohort yielded a high discriminative power (92% for colectomy and 72% for progressivedisease).
Conclusions: This study allowed the construction of risk matrices that can be used to accurately predict a UC patient's likelihood of requiring a colectomy or of facing progressive disease and can be used to individualize therapeutic strategies.
Material and Methods: This was a multicenter study: patients' data (n=1481) was retrieved from the Portuguese database of inflammatory bowel disease patients. Bayesian networks and logistic regression were used to build risk matrices concerning the outcomes of interest.
Results: The derivation cohort included a total of 1210 patients, of which 6% required a colectomy and 37% had progressive disease (over a median follow-up period of 12 years). The risk matrices show that previously hospitalized patients with extensive disease who are not on immunomodulators and who are refractory to corticosteroid treatment are the ones at the highest risk of undergoing a colectomy (88%), whereas male patients with extensive disease and less than 40 years old at diagnosis are the ones at the highest risk of experiencing progressive disease (72%). These results were internally- and externally-validated, and the AUC (area under the curve) of the ROC (receiver operating characteristic) analysis for the derivation cohort yielded a high discriminative power (92% for colectomy and 72% for progressivedisease).
Conclusions: This study allowed the construction of risk matrices that can be used to accurately predict a UC patient's likelihood of requiring a colectomy or of facing progressive disease and can be used to individualize therapeutic strategies.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app